Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies

Front Oncol. 2023 May 31:13:1215332. doi: 10.3389/fonc.2023.1215332. eCollection 2023.

Julie Decock^{1

2}, Giuseppina Comito³, Apostolos Zaravinos^{4

5}

¹ Translational Cancer and Immunity Center (TCIC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.
² College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.
³ Department of Experimental and Clinical Biomedical Sciences, School of Mathematical, Physical and Natural Sciences, University of Florence, Florence, Italy.
⁴ Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus.
⁵ Cancer Genetics, Genomics and Systems Biology Laboratory, Basic and Translational Cancer Research Center (BTCRC), Nicosia, Cyprus.

No abstract available

Keywords: cancer; immunosuppression; immunotherapies; inflammation; resistance; tumor microenvironment.

Publication types

This work was supported by a grant from the Qatar Biomedical Research Institute (#VR94-IGP3-2020), awarded to JD.